IRIS Accounts Production v23.1.0.753 14049984 Board of Directors Board of Directors 15.4.22 30.4.23 30.4.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure140499842022-04-14140499842023-04-30140499842022-04-152023-04-30140499842022-04-1414049984ns15:EnglandWales2022-04-152023-04-3014049984ns14:PoundSterling2022-04-152023-04-3014049984ns10:Director12022-04-152023-04-3014049984ns10:Director22022-04-152023-04-3014049984ns10:PrivateLimitedCompanyLtd2022-04-152023-04-3014049984ns10:Micro-entities2022-04-152023-04-3014049984ns10:AuditExempt-NoAccountantsReport2022-04-152023-04-3014049984ns10:FullAccounts2022-04-152023-04-3014049984ns10:RegisteredOffice2022-04-152023-04-3014049984ns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 14049984 (England and Wales)















Unaudited Financial Statements for the Period 15 April 2022 to 30 April 2023

for

Soliman Medical Limited

Soliman Medical Limited (by shares) (Registered number: 14049984)






Contents of the Financial Statements
for the Period 15 April 2022 to 30 April 2023




Page

Company Information 1

Balance Sheet 2


Soliman Medical Limited (by shares)

Company Information
for the Period 15 April 2022 to 30 April 2023







DIRECTORS: Dr. A M A Soliman
Mrs A Mohamed





REGISTERED OFFICE: 19 Pendle Drive
Whalley
Clitheroe
BB7 9JT





REGISTERED NUMBER: 14049984 (England and Wales)






Soliman Medical Limited (by shares) (Registered number: 14049984)

Balance Sheet
30 April 2023

£    £   
FIXED ASSETS 333

CURRENT ASSETS 89,733

CREDITORS
Amounts falling due within one year (41,110 )
NET CURRENT ASSETS 48,623
TOTAL ASSETS LESS CURRENT
LIABILITIES

48,956

CAPITAL AND RESERVES 48,956

NOTE TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 3 .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 April 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 April 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 25 September 2023 and were signed on its behalf by:




Dr. A M A Soliman - Director



Mrs A Mohamed - Director